Shivaji Manthena

446 total citations
20 papers, 296 citations indexed

About

Shivaji Manthena is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shivaji Manthena has authored 20 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shivaji Manthena's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Shivaji Manthena is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Shivaji Manthena collaborates with scholars based in United States, United Kingdom and Canada. Shivaji Manthena's co-authors include Mondira Bhattacharya, Robert W. Baran, Charles M. Gerrits, Stuart Kupfer, Alfonso García‐Pérez, Steven E. Marx, Patrick M. Reilly, Atul Deodhar, J. Anderson and Avani Joshi and has published in prestigious journals such as Blood, Journal of Hepatology and Obstetrics and Gynecology.

In The Last Decade

Shivaji Manthena

20 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shivaji Manthena United States 8 93 72 69 67 59 20 296
Yagil Barazani United States 8 25 0.3× 39 0.5× 58 0.8× 72 1.1× 41 0.7× 19 305
Sebahat Yılmaz Ağladıoğlu Türkiye 12 193 2.1× 19 0.3× 28 0.4× 10 0.1× 124 2.1× 31 355
Sergio Rodriguez Spain 10 17 0.2× 13 0.2× 72 1.0× 30 0.4× 58 1.0× 21 302
P. Hines United States 6 36 0.4× 181 2.5× 100 1.4× 113 1.7× 11 0.2× 11 406
J. Körber Germany 9 16 0.2× 12 0.2× 185 2.7× 125 1.9× 28 0.5× 11 411
Tracey Johnston United Kingdom 10 5 0.1× 20 0.3× 39 0.6× 28 0.4× 39 0.7× 26 321
Tom Creed United Kingdom 9 10 0.1× 18 0.3× 123 1.8× 29 0.4× 41 0.7× 21 330
Richele Bettencourt United States 9 280 3.0× 5 0.1× 201 2.9× 119 1.8× 66 1.1× 16 503
Yayi Hu China 10 11 0.1× 10 0.1× 33 0.5× 8 0.1× 37 0.6× 38 314
Yohei Ogawa Japan 12 76 0.8× 4 0.1× 66 1.0× 8 0.1× 77 1.3× 34 322

Countries citing papers authored by Shivaji Manthena

Since Specialization
Citations

This map shows the geographic impact of Shivaji Manthena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shivaji Manthena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shivaji Manthena more than expected).

Fields of papers citing papers by Shivaji Manthena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shivaji Manthena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shivaji Manthena. The network helps show where Shivaji Manthena may publish in the future.

Co-authorship network of co-authors of Shivaji Manthena

This figure shows the co-authorship network connecting the top 25 collaborators of Shivaji Manthena. A scholar is included among the top collaborators of Shivaji Manthena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shivaji Manthena. Shivaji Manthena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shewale, Anand R., Weijie Poh, Michael L. Reed, et al.. (2024). Ubrogepant users' real‐world experience: Patients on ubrogepant, characteristics and outcomes (UNIVERSE) study. Headache The Journal of Head and Face Pain. 64(10). 1244–1252. 1 indexed citations
2.
Martinez, Anthony, Wei‐Han Cheng, Steven E. Marx, et al.. (2023). Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study. Advances in Therapy. 40(8). 3465–3477. 2 indexed citations
3.
Reau, Nancy, Mark Sulkowski, Emmanuel Thomas, et al.. (2021). Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017–2019. Advances in Therapy. 38(12). 5777–5790. 9 indexed citations
4.
Lamvu, Georgine, Ahmed M. Soliman, Shivaji Manthena, et al.. (2019). Patterns of Prescription Opioid Use in Women With Endometriosis. Obstetrics and Gynecology. 133(6). 1120–1130. 35 indexed citations
5.
Lamvu, Georgine, et al.. (2019). Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With Benzodiazepines. Obstetrical & Gynecological Survey. 74(9). 526–528. 2 indexed citations
6.
Manthena, Shivaji, et al.. (2019). Economic Burden of Multiple Myeloma: Results from a Large Employer-Sponsored Real-World Administrative Claims Database, 2012 to 2018. Blood. 134(Supplement_1). 3414–3414. 2 indexed citations
7.
8.
Chirikov, Viktor, et al.. (2018). Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013–2016. Advances in Therapy. 35(7). 1087–1102. 24 indexed citations
9.
Hepp, Zsolt, Kathleen Wyne, Shivaji Manthena, Siting Wang, & Ved V. Gossain. (2018). Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis. Current Medical Research and Opinion. 34(9). 1673–1678. 26 indexed citations
10.
Deodhar, Atul, Manish Mittal, Patrick M. Reilly, et al.. (2016). Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay. Clinical Rheumatology. 35(7). 1769–1776. 70 indexed citations
11.
Walker, David, et al.. (2015). P0719 : Healthcare costs by stage of liver disease in chronic hepatitis C patients in the United States. Journal of Hepatology. 62. S593–S594. 1 indexed citations
12.
Walker, David, et al.. (2015). Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV). Advances in Therapy. 32(11). 1117–1127. 23 indexed citations
13.
Walker, David, et al.. (2015). The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir. ClinicoEconomics and Outcomes Research. 7. 637–637. 7 indexed citations
14.
Walker, David, et al.. (2015). P0864 : The impact of ribavirin on real world adherence and discontinuation rates in HCV patients treated with sofosbuvir + simeprevir. Journal of Hepatology. 62. S664–S664. 1 indexed citations
15.
Mitchell, Ian, et al.. (2014). The Disease Burden Associated With Infant Hospitalization For A Lower Respiratory Tract Infection (Lrti) In Canada. Value in Health. 17(3). A179–A179. 2 indexed citations
16.
Manthena, Shivaji, et al.. (2010). Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events. Advances in Therapy. 27(4). 233–244. 6 indexed citations
17.
Manthena, Shivaji, et al.. (2010). Association between HDL-C concentration and risk for a major cardiovascular event. Current Medical Research and Opinion. 26(4). 933–941. 9 indexed citations
18.
Manthena, Shivaji, et al.. (2009). PCV3 HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND RISK FOR MAJOR CARDIOVASCULAR EVENTS IN MEN AND WOMEN. Value in Health. 12(7). A500–A500. 1 indexed citations
19.
Gerrits, Charles M., Mondira Bhattacharya, Shivaji Manthena, et al.. (2007). A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes. Pharmacoepidemiology and Drug Safety. 16(10). 1065–1071. 67 indexed citations
20.
Gerrits, Charles M., Mondira Bhattacharya, Shivaji Manthena, et al.. (2007). A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes. Pharmacoepidemiology and Drug Safety. 16(12). 1314–1316. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yagil Barazani Breakdown of academic impact, for papers by Sebahat Yılmaz Ağladıoğlu Breakdown of academic impact, for papers by Sergio Rodriguez Breakdown of academic impact, for papers by P. Hines Breakdown of academic impact, for papers by J. Körber Breakdown of academic impact, for papers by Tracey Johnston Breakdown of academic impact, for papers by Tom Creed Breakdown of academic impact, for papers by Richele Bettencourt Breakdown of academic impact, for papers by Yayi Hu Breakdown of academic impact, for papers by Yohei Ogawa
Rankless by CCL
2026